MARK S. HUMAYUN, MD, PHD, FARVO is the Cornelius J. Pings Chair in Biomedical Sciences, Professor of Ophthalmology, Biomedical Engineering, and Integrative Anatomical Sciences, Director of the USC Ginsburg Institute for Biomedical Therapeutics, and Co-Director of the USC Roski Eye Institute.
Dr. Humayun is an internationally recognized pioneer in vision restoration. He assembled a team of multidisciplinary experts to develop the first FDA approved artificial retina,
Argus II, for sight restoration. He has more than 150 issued patents and over 300 peer reviewed publications. He has a google scholar H index of 106. Over 13,750 citations of his articles places him in the top 5% for citations within the Doximity community.
Dr. Humayun is a member of the U.S. National Academies of Medicine, Engineering, and Inventors. He is a Fellow of the American Association for the Advancement of Science (AAAS), Institute of Electrical and Electronics Engineers (IEEE), American Society of Retinal Specialists (ASRS), and Association for Research in Vision and Ophthalmology (ARVO).
For his extraordinary contributions he was awarded the United States’ highest technological achievement, the 2015 National Medal of Technology and Innovation by President Obama. He is the recipient of the 2018 IEEE Biomedical Engineering Award, the 2020 IEEE Medal for Innovations in Healthcare Technology, and the Charles Schepens award by the American Academy of Ophthalmology in 2021. Dr. Humayun was named top 1% of ophthalmologists by the U.S. News & World Report.
